Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-18

FDA Approved: EPINASTINE HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved a supplemental application for epinastine hydrochloride (generic product) by Somerset Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epinastine hydrochloride (epinastine hydrochloride)

Snippet

SUPPL AP for EPINASTINE HYDROCHLORIDE (EPINASTINE HYDROCHLORIDE)